• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新诊断肺癌患者静脉血栓栓塞症的流行情况及其相关因素。

Prevalence and associations of VTE in patients with newly diagnosed lung cancer.

机构信息

Beijing Institute of Respiratory Medicine, Beijing Key Laboratory of Respiratory and Pulmonary Circulation Disorders, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China.

Beijing Institute of Respiratory Medicine, Beijing Key Laboratory of Respiratory and Pulmonary Circulation Disorders, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China.

出版信息

Chest. 2014 Sep;146(3):650-658. doi: 10.1378/chest.13-2379.

DOI:10.1378/chest.13-2379
PMID:24676401
Abstract

BACKGROUND

The risk of VTE before anticancer therapy in patients with lung cancer is not well defined.

METHODS

A total of 673 hospitalized patients with newly diagnosed lung cancer were examined for VTE within 1 week after admission at five hospitals between January 2009 and January 2011. Additionally, VTE diagnoses within the last 3 months were reviewed. All VTE events were confirmed with imaging studies. Blood cell count and serum carcinoembryonic antigen (CEA) levels were measured before initial treatment.

RESULTS

VTE events occurred in 89 of the 673 patients (13.2%) enrolled in this study. Forty-two patients (6.2%) developed lower extremity DVT alone, 33 patients (4.9%) developed pulmonary embolism (PE) alone, and 14 patients (2.1%) developed both DVT and PE. By multivariate logistic regression analysis, distant metastasis (OR, 2.2; 95% CI, 1.2-3.9) and leukocytosis (OR, 2.8; 95% CI, 1.5-5.4) were significantly associated with DVT, adenocarcinoma (OR, 2.1; 95% CI, 1.1-4.4) and anemia (OR, 4.6; 95% CI, 1.4-14.5) were significantly associated with PE, and an elevated CEA level in tertiles was linearly associated with PE (P for trend = .06). The area under the receiver operating characteristic curve for the prognostic or diagnostic CEA values was 0.68 (95% CI, 0.59-0.76; P < .001).

CONCLUSIONS

The prevalence of VTE was high in patients with newly diagnosed lung cancer. In patients with lung cancer, the factors associated with DVT might be different from those associated with PE. An elevated CEA level might facilitate the identification of patients at a higher risk of developing PE.

摘要

背景

在接受抗癌治疗之前,肺癌患者的静脉血栓栓塞(VTE)风险尚未明确。

方法

2009 年 1 月至 2011 年 1 月期间,我们在五家医院共检查了 673 例新诊断为肺癌且住院的患者,在入院后 1 周内检查 VTE,同时回顾过去 3 个月内的 VTE 诊断。所有 VTE 事件均通过影像学研究进行确认。在初始治疗前测量血细胞计数和血清癌胚抗原(CEA)水平。

结果

本研究共纳入 673 例患者,其中 89 例(13.2%)发生 VTE 事件。42 例(6.2%)患者仅发生下肢深静脉血栓形成,33 例(4.9%)患者仅发生肺栓塞(PE),14 例(2.1%)患者同时发生下肢深静脉血栓形成和 PE。多变量 logistic 回归分析显示,远处转移(OR,2.2;95%CI,1.2-3.9)和白细胞增多症(OR,2.8;95%CI,1.5-5.4)与 DVT 显著相关,腺癌(OR,2.1;95%CI,1.1-4.4)和贫血(OR,4.6;95%CI,1.4-14.5)与 PE 显著相关,CEA 水平的三分位与 PE 呈线性相关(趋势 P=.06)。预测或诊断 CEA 值的受试者工作特征曲线下面积为 0.68(95%CI,0.59-0.76;P<0.001)。

结论

新发肺癌患者的 VTE 患病率较高。在肺癌患者中,与 DVT 相关的因素可能与与 PE 相关的因素不同。CEA 水平升高可能有助于识别发生 PE 风险较高的患者。

相似文献

1
Prevalence and associations of VTE in patients with newly diagnosed lung cancer.新诊断肺癌患者静脉血栓栓塞症的流行情况及其相关因素。
Chest. 2014 Sep;146(3):650-658. doi: 10.1378/chest.13-2379.
2
Comparison among different presentations of venous thromboembolism because of lung cancer.肺癌所致静脉血栓栓塞不同表现形式的比较。
Clin Respir J. 2019 Sep;13(9):574-582. doi: 10.1111/crj.13060. Epub 2019 Aug 7.
3
Incidence and Clinical Characteristic of Venous Thromboembolism in Gynecologic Oncology Patients attending King Chulalongkorn Memorial Hospital over a 10 Year Period.朱拉隆功国王纪念医院10年间妇科肿瘤患者静脉血栓栓塞的发病率及临床特征
Asian Pac J Cancer Prev. 2015;16(15):6705-9. doi: 10.7314/apjcp.2015.16.15.6705.
4
Hypertension associated with venous thromboembolism in patients with newly diagnosed lung cancer.新诊断肺癌患者中与静脉血栓栓塞相关的高血压
Sci Rep. 2016 Jan 22;6:19603. doi: 10.1038/srep19603.
5
Prevalence and clinical significance of incidental and clinically suspected venous thromboembolism in lung cancer patients.肺癌患者中偶然发现和临床疑似静脉血栓栓塞症的流行率和临床意义。
Clin Lung Cancer. 2013 Nov;14(6):713-8. doi: 10.1016/j.cllc.2013.06.003. Epub 2013 Jul 26.
6
Prevalence of venous thromboembolic events and diagnostic performance of the wells score and revised geneva scores for pulmonary embolism in patients with interstitial lung disease: a prospective study.间质性肺疾病患者静脉血栓栓塞事件的患病率以及Wells评分和修订的肺栓塞Geneva评分的诊断效能:一项前瞻性研究
Heart Lung Circ. 2014 Aug;23(8):778-85. doi: 10.1016/j.hlc.2014.02.014. Epub 2014 Mar 12.
7
Prospective analysis of risk factors and distribution of venous thromboembolism in the population-based Malmö Thrombophilia Study (MATS).基于人群的马尔默血栓形成倾向研究(MATS)中静脉血栓栓塞的风险因素和分布的前瞻性分析。
Thromb Res. 2009 Dec;124(6):663-6. doi: 10.1016/j.thromres.2009.04.022. Epub 2009 Jun 3.
8
Association between Level of Tumor Markers and Development of VTE in Patients with Pancreatic, Colorectal and Ovarian Ca: Retrospective Case- Control Study in Two Community Hospitals.胰腺癌、结直肠癌和卵巢癌患者肿瘤标志物水平与静脉血栓栓塞症发生之间的关联:两家社区医院的回顾性病例对照研究
Pathol Oncol Res. 2018 Apr;24(2):283-287. doi: 10.1007/s12253-017-0239-x. Epub 2017 May 4.
9
Impact of venous thromboembolism on the natural history of pancreatic adenocarcinoma.静脉血栓栓塞对胰腺腺癌自然病程的影响。
Hepatobiliary Pancreat Dis Int. 2015 Aug;14(4):436-42. doi: 10.1016/s1499-3872(15)60397-6.
10
Venous thromboembolism: deep venous thrombosis and pulmonary embolism in a neurosurgical population.静脉血栓栓塞症:神经外科人群中的深静脉血栓形成和肺栓塞。
J Neurosurg. 2011 Jan;114(1):40-6. doi: 10.3171/2010.8.JNS10332. Epub 2010 Sep 3.

引用本文的文献

1
The Association Between Thromboembolic Events and ALK, ROS1, RET Rearrangements or EGFR Mutations in Patients With Advanced Lung Adenocarcinoma: A Retrospective Cohort Study.晚期肺腺癌患者血栓栓塞事件与ALK、ROS1、RET重排或EGFR突变之间的关联:一项回顾性队列研究
Thorac Cancer. 2025 Aug;16(15):e70141. doi: 10.1111/1759-7714.70141.
2
Machine learning-based preoperative prediction of perioperative venous thromboembolism in Chinese lung cancer patients: a retrospective cohort study.基于机器学习的中国肺癌患者围手术期静脉血栓栓塞症的术前预测:一项回顾性队列研究
Front Oncol. 2025 Jun 25;15:1588817. doi: 10.3389/fonc.2025.1588817. eCollection 2025.
3
Incidence of pulmonary embolism and its risk factors in lung cancer patients: a systematic review and meta-analysis.
肺癌患者肺栓塞的发病率及其危险因素:一项系统评价和荟萃分析。
Discov Oncol. 2025 Jul 7;16(1):1279. doi: 10.1007/s12672-025-02720-y.
4
TMEM132A: a novel susceptibility gene for lung adenocarcinoma combined with venous thromboembolism identified through comprehensive bioinformatic analysis.TMEM132A:通过综合生物信息学分析鉴定出的肺腺癌合并静脉血栓栓塞的新型易感基因。
Front Oncol. 2025 May 13;15:1564114. doi: 10.3389/fonc.2025.1564114. eCollection 2025.
5
Adverse event profile of crizotinib in real-world from the FAERS database: a 12-year pharmacovigilance study.基于FAERS数据库的克唑替尼在真实世界中的不良事件概况:一项为期12年的药物警戒研究
BMC Pharmacol Toxicol. 2025 Mar 14;26(1):61. doi: 10.1186/s40360-025-00859-6.
6
A novel classification method for LUAD that guides personalized immunotherapy on the basis of the cross-talk of coagulation- and macrophage-related genes.一种基于凝血和巨噬细胞相关基因相互作用指导个性化免疫治疗的肺腺癌新型分类方法。
Front Immunol. 2025 Feb 13;16:1518102. doi: 10.3389/fimmu.2025.1518102. eCollection 2025.
7
Rivaroxaban versus low molecular weight heparin for managing lower extremity deep vein thrombosis following thoracoscopic lung cancer surgery: a randomized controlled trial.利伐沙班与低分子量肝素用于胸腔镜肺癌手术后下肢深静脉血栓形成的管理:一项随机对照试验
J Cardiothorac Surg. 2025 Jan 20;20(1):77. doi: 10.1186/s13019-024-03225-5.
8
Prevalence and clinical characteristics of venous thromboembolism in patients with lung cancer: a systematic review and meta-analysis.肺癌患者静脉血栓栓塞症的患病率及临床特征:一项系统评价和荟萃分析。
Front Oncol. 2024 Aug 14;14:1405147. doi: 10.3389/fonc.2024.1405147. eCollection 2024.
9
Tumor-infiltrating platelets promote the growth of lung adenocarcinoma.肿瘤浸润血小板促进肺腺癌生长。
Transl Oncol. 2024 Jan;39:101813. doi: 10.1016/j.tranon.2023.101813. Epub 2023 Oct 27.
10
Comprehensive analyses for the coagulation and macrophage-related genes to reveal their joint roles in the prognosis and immunotherapy of lung adenocarcinoma patients.全面分析凝血和巨噬细胞相关基因,揭示它们在肺腺癌患者预后和免疫治疗中的联合作用。
Front Immunol. 2023 Oct 31;14:1273422. doi: 10.3389/fimmu.2023.1273422. eCollection 2023.